MariMed Inc. (OTCMKTS:MRMD) Short Interest Update

MariMed Inc. (OTCMKTS:MRMD) was the recipient of a large increase in short interest in July. As of July 15th, there was short interest totaling 3,893 shares, an increase of 108.6% from the June 30th total of 1,866 shares. Based on an average daily trading volume, of 548,629 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.0% of the company’s shares are short sold.

MariMed Trading Down 4.7%

Shares of OTCMKTS MRMD traded down $0.00 during midday trading on Thursday, hitting $0.06. The stock had a trading volume of 144,503 shares, compared to its average volume of 525,124. The company’s 50-day simple moving average is $0.07 and its 200 day simple moving average is $0.08. The firm has a market cap of $25.92 million, a P/E ratio of -2.15 and a beta of 1.32. MariMed has a fifty-two week low of $0.06 and a fifty-two week high of $0.23. The company has a debt-to-equity ratio of 1.67, a current ratio of 0.95 and a quick ratio of 0.34.

MariMed (OTCMKTS:MRMD) last issued its quarterly earnings results on Wednesday, May 13th. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.01). The business had revenue of $39.48 million for the quarter, compared to analyst estimates of $38.75 million. MariMed had a negative return on equity of 5.00% and a negative net margin of 7.82%.

About MariMed

MariMed Inc is a multi‐state cannabis company focused on the development, ownership and operation of regulated facilities for the medical and adult‐use cannabis markets. Headquartered in New Bedford, Massachusetts, the company cultivates, processes and dispenses cannabis through an integrated business model that encompasses cultivation, formulation, manufacturing and retail operations. MariMed operates under its own licensed brands and through strategic partnerships to expand its presence across the United States.

The company’s product portfolio includes branded flower, pre‐rolls, vaporizer cartridges, tinctures, edibles and topicals designed to meet a range of consumer and patient needs.